Literature DB >> 32484122

Accuracy of real-time polymerase chain reaction to detect Schistosoma mansoni - infected individuals from an endemic area with low parasite loads.

Fernanda do Carmo Magalhães1, Samira Diniz Resende1, Carolina Senra2, Carlos Graeff-Teixeira3, Martin Johannes Enk4, Paulo Marcos Zech Coelho5, Edward Oliveira2, Deborah Aparecida Negrão-Corrêa1, Stefan Michael Geiger1, Mariângela Carneiro1.   

Abstract

Due to the efforts to control schistosomiasis transmission in tropical countries, a large proportion of individuals from endemic areas present low parasite loads, which hinders diagnosis of intestinal schistosomiasis by the Kato-Katz (KK) method. Therefore, the development of more sensitive diagnostic methods is essential for efficient control measures. The aim was to evaluate the accuracy of a real-time polymerase chain reaction (RT-PCR) to detect Schistosoma mansoni DNA in fecal samples of individuals with low parasite loads. A cross-sectional population-based study was conducted in a rural community (n = 257) in Brazil. POC-CCA® was performed in urine and feces were used for RT-PCR. In addition, fecal exams were completed by 18 KK slides, saline gradient and Helmintex techniques. The combined results of the three parasitological tests detected schistosome eggs in 118 participants (45.9%) and composed the consolidated reference standard (CRS). By RT-PCR, 117 out of 215 tested samples were positive, showing 91.4% sensitivity, 80.2% specificity and good concordance with the CRS (kappa = 0.71). RT-PCR identified 86.9% of the individuals eliminating less than 12 eggs/g of feces, demonstrating much better performance than POC-CCA® (50.8%). Our results showed that RT-PCR is a valuable alternative for the diagnosis of intestinal schistosomiasis in individuals with very low parasite loads.

Entities:  

Keywords:  Diagnosis; RT-PCR; Schistosomiasis mansoni; low parasite load

Mesh:

Substances:

Year:  2020        PMID: 32484122     DOI: 10.1017/S003118202000089X

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  5 in total

Review 1.  The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game.

Authors:  Paul Ogongo; Ruth K Nyakundi; Gerald K Chege; Lucy Ochola
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

2.  Previous History of American Tegumentary Leishmaniasis Alters Susceptibility and Immune Response Against Schistosoma mansoni Infection in Humans.

Authors:  Guilherme Silva Miranda; Samira Diniz Resende; Diogo Tavares Cardoso; Genil Mororó Araújo Camelo; Jeferson Kelvin Alves Oliveira Silva; Vanessa Normandio de Castro; Stefan Michael Geiger; Mariângela Carneiro; Deborah Negrão-Corrêa
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

3.  A Real-Time PCR Assay for the Diagnosis of Intestinal Schistosomiasis and Cure Assessment After the Treatment of Individuals With Low Parasite Burden.

Authors:  Liliane Maria Vidal Siqueira; Carolina Senra; Áureo Almeida de Oliveira; Nidia Francisca de Figueiredo Carneiro; Luciana Inácia Gomes; Ana Rabello; Paulo Marcos Zech Coelho; Edward Oliveira
Journal:  Front Immunol       Date:  2021-03-16       Impact factor: 7.561

4.  Development of a Recombinase Polymerase Amplification Assay for Schistosomiasis Japonica Diagnosis in the Experimental Mice and Domestic Goats.

Authors:  Qinghong Guo; Kerou Zhou; Cheng Chen; Yongcheng Yue; Zheng Shang; Keke Zhou; Zhiqiang Fu; Jinming Liu; Jiaojiao Lin; Chenyang Xia; Wenqiang Tang; Xiaonan Cong; Xuejun Sun; Yang Hong
Journal:  Front Cell Infect Microbiol       Date:  2021-11-16       Impact factor: 5.293

5.  Reliability of point-of-care circulating cathodic antigen assay for diagnosing schistosomiasis mansoni in urine samples from an endemic area of Brazil after one year of storage at -20 degrees Celsius.

Authors:  Tereza Cristina Favre; Lilian Christina Nóbrega Holsback Beck; Fernando Schemelzer Moraes Bezerra; Carlos Graeff-Teixeira; Paulo Marcos Zech Coelho; Martin Johannes Enk; Naftale Katz; Ricardo Riccio Oliveira; Mitermayer Galvão Dos Reis; Otávio Sarmento Pieri
Journal:  Rev Soc Bras Med Trop       Date:  2022-02-25       Impact factor: 1.581

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.